Izote
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Izote - overview
Established
2022
Location
Berkeley, CA, US
Primary Industry
Biotechnology
About
Based in California, US, and founded in 2022, Izote operates as a biotechnology that develops a solution for fermentation, offering a process for microbial hosts to function without oxygen. In February 2024, Izote raised USD 2. 6 million in pre-seed funding co-led by EGB Capital and Embark Ventures, with participation from Bee Partners, Climate Capital Syndicate, Courtyard Ventures, FTW Ventures, Nucleus Capital, and Redstick Ventures. Izote is a fermentation technology company revolutionizing industrial biomanufacturing with its anaerobic process.
Their approach allows microbial hosts to thrive without oxygen, simplifying fermentation design and offering highly predictable scaling of performance. The Izote system boasts significant reductions in operational expenses, energy usage, and capital expenditures. It removes limitations on tank size, accelerates scale-up processes, and enables the use of low-cost feedstocks.
Current Investors
Bee Partners, FTW Ventures, Embark Ventures
Primary Industry
Biotechnology
Sub Industries
Molecular Science, Genetics & Gene Therapy
Website
www.izote.bio
Company Stage
Early Stage
Total Amount Raised
Subscriber access only
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.